Jazz Pharmaceuticals (JAZZ) Other Accumulated Expenses (2010 - 2012)

Jazz Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $18.9 million for Q2 2012.

• In Q2 2012, Other Accumulated Expenses changed N/A year-over-year to $18.9 million; the TTM figure through Jun 2012 stood at $18.9 million (changed N/A YoY), while the FY2011 annual figure was $2.4 million, up 135.65% from the prior year.
• Other Accumulated Expenses for Q2 2012 stood at $18.9 million, up from $8.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $18.9 million in Q2 2012, with the low at $1.0 million in Q4 2010.
• The 3-year median for Other Accumulated Expenses is $5.3 million (2011), against an average of $7.6 million.
• Peak annual rise in Other Accumulated Expenses reached 135.65% in 2011, while the deepest fall reached 135.65% in 2011.
• Jazz Pharmaceuticals' Other Accumulated Expenses stood at $1.0 million in 2010, then soared by 135.65% to $2.4 million in 2011, then jumped by 673.8% to $18.9 million in 2012.
• Business Quant data shows JAZZ's Other Accumulated Expenses at $18.9 million in Q2 2012, $8.2 million in Q1 2012, and $2.4 million in Q4 2011.